Libtayo – Display Banners Conference – 29733
ASCO a Focus on NMSC eBook
ASCO NMSC Annual Meetingv1.indd
Tumor Suppressor Genes Frequently Altered in Squamous Cell Carcinoma
Tumor suppressor genes, including TP53, TERT, KMT2D, NOTCH1, NOTCH2, and FAT1, were often altered...
Treatment for Sézary Syndrome Increases
The use of systemic and skin-directed therapies increased among patients with Sézary syndrome...
Determining Whether Adding RP1 to Cemiplimab Helps CSCC Patients
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab
High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to...
ASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Continuing Education At ASCO 2022
Sessions at the 2022 ASCO Annual Meeting offer Continuing Medical Education (CME) credits and ABIM and ABP Maintenance of Certification (MOC) points for physicians. Nursing and pharmacy CE credits will not be provided this year,...
Why To Attend ASCO 2022
Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Neoadjuvant Immunotherapy for Advanced, Resectable CSCC-HN
Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...
Usage of Immunotherapy in Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...
Treatment Resistant HPV+ Head & Neck Squamous Cell Carcinoma
Cancer’s biological behavior was exceedingly complex, driven by the nonlinear interplay of...
